Results 131 to 140 of about 12,053 (162)

Hypertriglyceridemia in chronic kidney disease: pathophysiological mechanisms, cardiovascular risk, and emerging therapeutics. [PDF]

Lipids Health Dis
Li D, Liu Z, Jiang H.
europepmc   +1 more source

Associations and predictive value of weight-adjusted waist index for cardiovascular outcomes in type 2 diabetes: evidence from the ACCORD study. [PDF]

Nutr J
Liu M, Pei J, Zeng C, Xin Y, Tang P, Hu X.   +5 more
europepmc   +1 more source

Comparative effectiveness of pemafibrate versus bezafibrate on hepatic and vascular endothelial function in patients with coronary artery disease and metabolic dysfunction-associated steatotic liver disease. [PDF]

Front Endocrinol (Lausanne)
Nakamura A, Kagaya Y, Saito H, Kanazawa M, Miura M, Kondo M, Endo H.   +6 more
europepmc   +1 more source

The association between atherogenic index of plasma and cognitive impairment among older adults in Southern Iran: findings from the Bushehr elderly health program. [PDF]

BMC Geriatr
Eslami MH, Sedokani A, Panahi N, Sharifi F, Payab M, Ebrahimpour M, Zarinfar Y, Fahimfar N, Nabipour I, Heshmat R, Larijani B, Ostovar A.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fibrates

2005
Atherosclerosis of the large arteries is the main origin of cerebro- and cardiovascular diseases, the leading causes of mortality and morbidity in industrialized countries. The pathophysiology of coronary and cerebrovascular atherosclerosis is multifactorial and complex. Fibrates are hypolipidemic drugs that lower progression of atherosclerotic lesions
R, Robillard, C, Fontaine, G, Chinetti, J C, Fruchart, B, Staels   +4 more
openaire   +2 more sources